athenahealth, Inc. (NASDAQ:ATHN) had its price target reduced by stock analysts at Leerink Swann from $155.00 to $125.00 in a report released on Monday. The brokerage presently has a “market perform” rating on the health services provider’s stock. Leerink Swann’s target price suggests a potential downside of 1.37% from the stock’s current price.

Several other equities research analysts have also recently commented on ATHN. Wells Fargo & Company cut their price target on athenahealth from $190.00 to $155.00 and set an “outperform” rating for the company in a report on Monday. Robert W. Baird reaffirmed a “buy” rating and issued a $155.00 price target (down previously from $170.00) on shares of athenahealth in a report on Sunday. First Analysis raised athenahealth from an “underweight” rating to an “equal weight” rating and increased their price target for the company from $125.00 to $127.00 in a report on Monday. Canaccord Genuity reaffirmed a “hold” rating and issued a $123.00 price target (down previously from $144.00) on shares of athenahealth in a report on Monday. Finally, SunTrust Banks, Inc. reaffirmed a “buy” rating and issued a $170.00 price target (up previously from $150.00) on shares of athenahealth in a report on Wednesday, August 2nd. Two equities research analysts have rated the stock with a sell rating, fourteen have issued a hold rating and eleven have assigned a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus target price of $144.91.

athenahealth (NASDAQ:ATHN) traded up 0.46% during trading on Monday, hitting $126.62. The stock had a trading volume of 929,501 shares. The company has a market cap of $5.06 billion, a PE ratio of 160.69 and a beta of 1.76. The company’s 50 day moving average is $125.37 and its 200-day moving average is $130.33. athenahealth has a 12 month low of $90.11 and a 12 month high of $158.66.

athenahealth (NASDAQ:ATHN) last posted its quarterly earnings results on Thursday, October 19th. The health services provider reported $0.56 EPS for the quarter, beating the consensus estimate of $0.50 by $0.06. athenahealth had a return on equity of 6.94% and a net margin of 2.65%. The firm had revenue of $304.60 million during the quarter, compared to analysts’ expectations of $310.52 million. During the same quarter last year, the firm earned $0.60 earnings per share. The business’s revenue for the quarter was up 10.1% on a year-over-year basis. On average, equities research analysts predict that athenahealth will post $1.97 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: This news story was reported by American Banking News and is the sole property of of American Banking News. If you are viewing this news story on another site, it was illegally copied and reposted in violation of U.S. and international trademark and copyright legislation. The correct version of this news story can be accessed at https://www.americanbankingnews.com/2017/10/23/athenahealth-inc-athn-pt-lowered-to-125-00.html.

In related news, insider Daniel P. Haley sold 1,583 shares of athenahealth stock in a transaction on Monday, October 2nd. The stock was sold at an average price of $124.56, for a total value of $197,178.48. Following the completion of the transaction, the insider now directly owns 13,408 shares in the company, valued at $1,670,100.48. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Jonathan Bush sold 4,000 shares of athenahealth stock in a transaction on Tuesday, August 1st. The shares were sold at an average price of $143.31, for a total value of $573,240.00. Following the completion of the transaction, the chief executive officer now owns 319,807 shares of the company’s stock, valued at $45,831,541.17. The disclosure for this sale can be found here. Over the last quarter, insiders sold 15,783 shares of company stock valued at $2,132,924. 3.20% of the stock is currently owned by company insiders.

Hedge funds and other institutional investors have recently made changes to their positions in the business. Elliott Management Corp purchased a new stake in athenahealth during the 2nd quarter worth about $52,706,000. UBS Asset Management Americas Inc. lifted its holdings in athenahealth by 33.2% during the 2nd quarter. UBS Asset Management Americas Inc. now owns 30,536 shares of the health services provider’s stock worth $4,292,000 after buying an additional 7,605 shares during the last quarter. Scout Investments Inc. lifted its holdings in athenahealth by 67.2% during the 2nd quarter. Scout Investments Inc. now owns 115,663 shares of the health services provider’s stock worth $16,256,000 after buying an additional 46,507 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in athenahealth by 1.7% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 72,918 shares of the health services provider’s stock worth $10,249,000 after buying an additional 1,222 shares during the last quarter. Finally, Schwab Charles Investment Management Inc. lifted its holdings in athenahealth by 6.2% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 170,978 shares of the health services provider’s stock worth $24,031,000 after buying an additional 9,960 shares during the last quarter.

athenahealth Company Profile

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Analyst Recommendations for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.